RN Mobile Menu

Search form





Axial spondyloarthritis (SpA) often goes undiagnosed and is more common than previously thought, a study shows.


The diagnosis and treatment of spondyloarthritis (axSpA) and ankylosing spondylitis (AS) for primary healthcare providers.


Researchers say it's not necessary to take high body mass index into account in axial spondyloarthritis.


Patients with spondyloarthritis can confidently undergo treatment with tumor necrosis factor ⍺ inhibitors (TNFi) without fear of cancer risk.


Many new treatments for axial spondyloarthritis (SpA) have been introduced in recent years. This review summarizes current treatments for SpA.


New treatment guidelines for non-radiographic axial spondyloarthritis call for treatment with TNF blockers if NSAIDs fail.

Research highlights a need for closer partnerships between physicians and patients to set shared treatment goals.


Subscribe to Spondyloarthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.